New Hope Against a Rare but Incurable Eye Cancer

By Dennis Thompson HealthDay Reporter TUESDAY, April 20, 2021 (HealthDay News) — A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show. Tebentafusp has now become the first drug shown to improve overall survival in patients with … Read more